Allergan Looks Toward Smaller M&A


After the Allergan-Pfizer mega merger fell through earlier this year, many analysts wondered aloud what the next moves for both companies would be. Now, it seems that the answer is becoming clear for Allergan–the company will be looking at smaller mergers and acquisitions in order to boost growth. Allergan CEO Brent Saunders said that the company is looking to purchase “intellectual property, R&D assets, and with respect to M&A, smaller-scale tuck-in deals that will support our therapeutic area leadership and innovation.”


Read the source article at Bloomberg

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>